Found: 9
Select item for more details and to access through your institution.
Letter: Consensus in international guidelines when discontinuing nucleos(t)ide analogue therapy in patients with chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 954, doi. 10.1111/apt.17680
- By:
- Publication type:
- Article
A nurse-led, telehealth-driven hepatitis C management initiative in regional Victoria: Cascade of care from referral to cure.
- Published in:
- Journal of Telemedicine & Telecare, 2024, v. 30, n. 3, p. 497, doi. 10.1177/1357633X211024108
- By:
- Publication type:
- Article
The importance of prospective drug‐induced liver injury registries.
- Published in:
- Liver International, 2023, v. 43, n. 10, p. 2323, doi. 10.1111/liv.15687
- By:
- Publication type:
- Article
Validation of a novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study.
- Published in:
- Liver International, 2023, v. 43, n. 5, p. 989, doi. 10.1111/liv.15531
- By:
- Publication type:
- Article
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3288, doi. 10.1093/cid/ciaa1318
- By:
- Publication type:
- Article
Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2021, v. 25, p. 1, doi. 10.1016/j.aohep.2021.100549
- By:
- Publication type:
- Article
Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 4, p. 1496, doi. 10.1007/s10620-024-08354-4
- By:
- Publication type:
- Article
Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90‐day mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 5, p. 568, doi. 10.1111/apt.15365
- By:
- Publication type:
- Article
A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients.
- Published in:
- Nutrients, 2020, v. 12, n. 6, p. 1651, doi. 10.3390/nu12061651
- By:
- Publication type:
- Article